APA (7th ed.) Citation

L, C., A, F., S, L., L, G., G, B., M, F., . . . G, A. (2017). Cardiac safety of adjuvant non-pegylated liposomal doxorubicin combined with cyclophosphamide and followed by paclitaxel in older breast cancer patients. Breast (Edinburgh, Scotland), 31, 186. https://doi.org/10.1016/j.breast.2016.11.006

Chicago Style (17th ed.) Citation

L, Coltelli, et al. "Cardiac Safety of Adjuvant Non-pegylated Liposomal Doxorubicin Combined with Cyclophosphamide and Followed by Paclitaxel in Older Breast Cancer Patients." Breast (Edinburgh, Scotland) 31 (2017): 186. https://doi.org/10.1016/j.breast.2016.11.006.

MLA (9th ed.) Citation

L, Coltelli, et al. "Cardiac Safety of Adjuvant Non-pegylated Liposomal Doxorubicin Combined with Cyclophosphamide and Followed by Paclitaxel in Older Breast Cancer Patients." Breast (Edinburgh, Scotland), vol. 31, 2017, p. 186, https://doi.org/10.1016/j.breast.2016.11.006.